BOOK REVIEWS

“For men who wish to fight the fear of prostate cancer with knowledge, this is the book.”

–WILLIAM CASSIDY, MD, UNITED STATES SENATOR

"Prostate cancer is an intricate and challenging problem;  Key provides modern solutions and begins a conversation about immunotherapy, the next-generation prostate cancer breakthrough."

–PATRICK SOON-SHIONG, MD, BILLIONAIRE, CHAIRMAN NANTWORKS
   

“This is the definitive reference for prostate cancer patients seeking to understand their disease and its treatment.”

–CHARLES "SNUFFY" MYERS, MD, VISIONARY PROSTATE ONCOLOGIST

“Key to Prostate Cancer uses patient-friendly language to explain a complex and rapidly changing field.”

–DAVID HUNG, MD, BILLIONAIRE, FORMER CEO MEDIVATION

WELCOME

A GUIDE TO PERSONALIZED CARE

Studies show that treatment choices based on partial information often lead to regret.  Patients struggle to pinpoint correct knowledge amidst a deluge of data overload.  With a short, self-administered quiz, KEY directs readers to targeted information that is stage-specific.  Written by 30 leading experts and edited by a prostate oncologist, KEY is a welcome antidote for an industry dominated by surgeons.

KEY is a synthesis of my lifelong career at Prostate Oncology Specialists, a medical practice on the forefront of prostate cancer for 20 years. My first book Invasion of the Prostate Snatchers was an exposé on the over-use of surgery. This second book addresses another burgeoning problem—the crisis of information overload. The explosion of new information overwhelms patients and doctors alike. Once men face a prostate cancer diagnosis the word “cancer” may lead to fearful thinking and a bad treatment decision. Good decisions result from hearing unbiased, balanced, and individualized advice.
This book directs patients to understand options and educate them about treatments specific for their stage of prostate cancer.
• A short STAGING QUIZ directs patients to their correct stage and which of the seven sections of the book to read.
• The book is divided into seven sections written by experts in prostate cancer. Five of the sections cover the FIVE STAGES OF BLUE.
• The average reader will only need to read three sections: Section I, which covers PSA, Gleason score and body scans, Section VII, which covers lifestyle and general health and only one of the additional sections—one that is  related to that patient’s prostate cancer stage.

About the Author

From the author of Invasion of the Prostate Snatchers, Mark Scholz, MD is the medical director of Prostate Oncology Specialists, Inc. He is also the executive director of the Prostate Cancer Research Institute. He received his medical degree from Creighton University, in Omaha, Nebraska. Dr. Scholz completed his internal medicine residency and medical oncology fellowship at the University of Southern California Medical Center. He is coauthor of Invasion of the Prostate Snatchers. He has authored over 20 scientific publications related to the treatment of prostate cancer.

Schedule a Consultation

Meet with one of Prostate Oncology Specialists author’s for a consultation – Drs. Mark Scholz, Richard Lam, or Jeffrey Turner.   Please fill out the application to schedule a consultation  @ www.prostateoncology.com/newpatient

Check out the Speaking Event Calendar

Learn about the prostate cancer stages, treatment options and more.  www.prostateoncology.com/events.  Request authors, Drs. Scholz, Lam or Turner to speak.  Email us at:  prostateoncology@gmail.com

30 EXPERT COAUTHORS

SECTION ONE

Staging and Prognosis

CHAPTER 1.  Quiz to Assign a Stage of Blue
Peter Scholz

CHAPTER 2. The PSA Blood Test
Stanley Brosman, MD

CHAPTER 3. Interpreting the Pathology Report
Jonathan Epstein, MD

CHAPTER 4. Multiparametric MRI and Targeted Biopsy
Daniel Margolis, MD

CHAPTER 5. Color Doppler Ultrasound and Targeted Biopsy
Duke Bahn, MD

CHAPTER 6.  Body Scans and Other Prognostic Factors
Fabio Almeida, MD

CHAPTER 7.  Picking the Right Doctor
Ralph Blum

SECTION TWO

The Sky Stage of Blue

CHAPTER 8. Overview of Sky
Mark Scholz, MD

CHAPTER 9. The Science Behind Active Surveillance
Laurence Klotz, MD

CHAPTER 10. Focal Cryosurgery
Duke Bahn, MD

CHAPTER 11. Introduction to Treatment-Related Side Effects
Mark Scholz, MD

CHAPTER 12. Sexual Dysfunction
Kelly Chiles, MD and John Mulhall, MD

CHAPTER 13. Surgical Side Effects Affecting Urination
Gary Leach, MD

CHAPTER 14. Side Effects from Radiation Therapy
Henry Yampolsky, MD

CHAPTER 15. Summary of Sky
Mark Scholz, MD

SECTION THREE

The Teal Stage of Blue

CHAPTER 16. Overview of Teal
Mark Scholz, MD

CHAPTER 17. Permanent Radioactive Seed Implants
Peter Grimm, DO and John Blasko, MD

CHAPTER 18. High-Dose-Rate Seeds
D. Jeffrey Demanes, MD

CHAPTER 19. IMRT for Teal
Zachary Zumsteg, MD and Howard Sandler, MD

CHAPTER 20. Combination Therapy for Intermediate-Risk
Sean McBride, MD and Michael Zelefsky, MD

CHAPTER 21. Proton Beam Therapy
Carl Rossi, MD

CHAPTER 22. Stereotactic Body Radiation Therapy (SBRT)
Michael Steinberg, MD

CHAPTER 23. TIP Alone as Primary Therapy for Teal
Mark Scholz, MD

CHAPTER 24. Robotic Radical Prostatectomy
Timothy Wilson, MD

CHAPTER 25. Comparing Treatments for Teal
Mark Scholz, MD

SECTION FOUR

The Azure Stage of Blue

CHAPTER 26. Overview of Azure
Mark Scholz, MD

CHAPTER 27. Testosterone Inactivating Pharmaceuticals (TIP)
Mark Scholz, MD

CHAPTER 28. The Azure Stage of Prostate Cancer
Mark Scholz, MD

CHAPTER 29. Unorthodox Therapies for High-Azure
Mark Scholz, MD

CHAPTER 30. Reducing the Side Effects of TIP
Mark Scholz, MD

SECTION FIVE

The Indigo Stage of Blue

CHAPTER 31. Overview of Indigo
Mark Scholz, MD

CHAPTER 32. Introduction to Radiation for Indigo
Christopher Rose, MD

CHAPTER 33. Indigo—Cancer Relapse or Pelvic Node Disease
Mark Scholz, MD

CHAPTER 34. Unorthodox Therapies for Indigo
Mark Scholz, MD

CHAPTER 35. Minimizing the Side Effects of Chemotherapy
Richard Lam, MD

CHAPTER 36. Indigo—Situations in which PSA is Misleading
Mark Scholz, MD

SECTION SIX

The Royal Stage of Blue

CHAPTER 37. Overview of Royal
Mark Scholz, MD

CHAPTER 38. Early Hormonal Resistance: Low-Royal
Mark Scholz, MD

CHAPTER 39. Oligometastatic Prostate Cancer: Basic-Royal
Jeffrey Turner, MD

CHAPTER 40. Treatments for High-Royal
Richard Lam, MD

CHAPTER 41. Unorthodox Therapies for Royal
Mark Scholz, MD

CHAPTER 42. Immunotherapy for Prostate Cancer
Charles Drake, MD

CHAPTER 43. Genetically Targeted Therapy
Mark Scholz, MD

CHAPTER 44. Cancer Research: Striving to Live Longer and Better
Luke Nordquist, MD

CHAPTER 45. Pain Management
Mark Scholz, MD

SECTION SEVEN

Lifestyle and General Health Issues

CHAPTER 46. Health Issues for Men with Prostate Cancer
Jeffrey Turner, MD

CHAPTER 47. Whole Nutrition for Prostate Health and Recovery
Verne Varona

CHAPTER 48. Fitness and Longevity
Mark Scholz, MD

CHAPTER 49. Supplements for Prostate Cancer
Mark Moyad, MD

CHAPTER 50. The Key: Knowing Your Stage of Blue
Mark Scholz, MD